Toll free

Toll-free:

1-877-681-6296
US & Canada

Downloadable

registry materials :

Click here to complete the form and mail or fax to PPD

Download a brochure describing the Belimumab Pregnancy Registry

Welcome to the Belimumab Pregnancy Registry Webpage for BENLYSTA Patients

Welcome to the Belimumab Pregnancy Registry Webpage for BENLYSTA Patients

  • This page contains information about the global Belimumab Pregnancy Registry that is monitoring pregnancy outcomes for women with systemic lupus erythematosus and their babies through the first year of life.
  • If you have taken at least 1 dose of BENLYSTA or belimumab within the 4 months prior to pregnancy (preconception) or during pregnancy you may be eligible to participate in the Belimumab Pregnancy Registry.
  • To participate in this registry study, you ARE NOT required to continue taking BENLYSTA or belimumab during your pregnancy and you WILL NOT be asked to take any medical exams or medications.
  • The Belimumab Pregnancy Registry is currently open in the US, Canada, Germany, Sweden, Spain, Slovakia, Austria and Belgium.  The Belimumab Pregnancy Registry will also open in other countries in the upcoming year(s). This site is intended for US and Canada residents only.

read more...

  • This page contains information about the global Belimumab Pregnancy Registry that is monitoring pregnancy outcomes for women with systemic lupus erythematosus and their babies through the first year of life
  • If you have taken at least 1 dose of BENLYSTA within the 4 months prior to pregnancy (preconception) or during pregnancy, you may be eligible to participate in the Belimumab Pregnancy Registry
  • To participate in this registry study, you ARE NOT required to continue taking BENLYSTA during your pregnancy and you WILL NOT be asked to take any additional medical exams or medications
  • The Belimumab Pregnancy Registry is currently open in the US, Canada, Germany, Sweden, Spain, Slovakia, Austria, Belgium and France. The Belimumab Pregnancy Registry will also open in other countries in the upcoming year(s). This site is intended for US and Canada residents only.

What is a pregnancy registry?

  • A pregnancy registry is a voluntary study that collects health information about your pregnancy, medical history, medications and infant outcomes
  • Pregnancy registries may help women and doctors or healthcare providers better understand how medicines affect pregnant women
  • For the Belimumab Pregnancy Registry, we will ask you to consent to participate in the registry and assent for your baby’s participation.  We will also ask you to give us contact information for your healthcare team, including your rheumatologist, obstetrical provider and pediatrician (once known).

How do I learn more about or enroll in the Belimumab Pregnancy Registry?

  • Call us toll-free at 1-877-681-6296 (US & Canada).
  • Download the consent to contact card and fax or mail to PPD
    • Fax: 1-855-269-6182
    • Mail: The Belimumab Pregnancy Registry Coordination Center
      PPD, Inc
      929 North Front Street
      Wilmington, NC 28401-3331

 

Toll-free:

1-877-681-6296 (US & Canada)?

Downloadable

Registry Materials